FTC: Delays in Generic Drugs on the Rise

(AP) -- Drug companies increasingly are reaching legal settlements that delay the introduction of cheaper generic medicines and cheat Americans of billions of dollars a year in savings, federal regulators on Wednesday told lawmakers seeking to ban the agreements.

If you want to include this story in your blog, copy and paste this formatted text: